​

CAMP4 Therapeutics (CAMP) Stock Forecast, Price Target & Predictions

OverviewChart

CAMP Stock Forecast

CAMP4 Therapeutics (CAMP) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $17.50, with a high of $18.00 and a low of $17.00. This represents a 783.84% increase from the last price of $1.98.

- $4 $8 $12 $16 $20 High: $18 Avg: $17.5 Low: $17 Last Closed Price: $1.98

CAMP Stock Rating

CAMP4 Therapeutics stock's rating consensus is Buy, based on 22 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (63.64%), 6 Hold (27.27%), 2 Sell (9.09%), and 0 Strong Sell (0.00%).

Buy
Total 22 0 2 6 14 Strong Sell Sell Hold Buy Strong Buy

CAMP Price Target Upside V Benchmarks

TypeNameUpside
StockCAMP4 Therapeutics783.84%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$17.50
Last Closing Price$1.98$1.98$1.98
Upside/Downside--783.84%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2522---4
Mar, 2522---4
Feb, 2522---4
Jan, 2522---4
Dec, 2422---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2024Mani ForooharLeerink Partners$17.00$9.6077.08%758.59%
Nov 05, 2024Edward TenthoffPiper Sandler$18.00$9.6087.50%809.09%
Aug 16, 2022Anthony StossCraig-Hallum$10.00$5.8072.41%405.05%
Jun 24, 2022Jerry RevichGoldman Sachs$5.00$4.931.42%152.53%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 05, 2024William BlairOutperforminitialise
Nov 05, 2024Leerink PartnersOutperforminitialise
Nov 05, 2024Piper SandlerOverweightinitialise
Jun 26, 2023Raymond JamesBuyupgrade
Oct 14, 2022Goldman SachsSellSellhold
Jun 24, 2022Goldman SachsSellSellhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Nov 20 Nov 21 Nov 22 Nov 23 Nov 24 Nov 25 Nov 26 Nov 27
Nov 20Nov 21Nov 22Nov 23Nov 24Nov 25Nov 26Nov 27
Reported---$-2.52----
Avg Forecast$2.86$0.77$-2.39$-5.27$-2.10$0.95$-2.42-
High Forecast$2.90$0.78$-2.39$-5.27$-1.29$1.01$-2.38-
Low Forecast$2.81$0.75$-2.39$-5.27$-3.23$0.86$-2.46-
Surprise %----52.18%----

Revenue Forecast

$150M $190M $230M $270M $310M $350M Nov 20 Nov 21 Nov 22 Nov 23 Nov 24 Nov 25 Nov 26 Nov 27
Nov 20Nov 21Nov 22Nov 23Nov 24Nov 25Nov 26Nov 27
Reported---$186.23M----
Avg Forecast$335.33M$295.88M$295.08M$237.48M$229.10M$252.01M$291.96M$152.47M
High Forecast$338.65M$298.80M$295.08M$237.48M$241.38M$264.74M$291.96M$152.47M
Low Forecast$330.91M$291.97M$295.08M$237.48M$216.83M$239.28M$291.96M$152.47M
Surprise %----21.58%----

Net Income Forecast

$-150M $-90M $-30M $30M $90M $150M Nov 20 Nov 21 Nov 22 Nov 23 Nov 24 Nov 25 Nov 26 Nov 27
Nov 20Nov 21Nov 22Nov 23Nov 24Nov 25Nov 26Nov 27
Reported---$-93.26M----
Avg Forecast$105.83M$-55.33M$-88.56M$-101.35M$-77.75M$34.69M$-89.58M-
High Forecast$107.19M$-44.26M$-88.56M$-81.08M$-47.71M$37.36M$-88.11M-
Low Forecast$104.02M$-66.39M$-88.56M$-121.62M$-119.61M$32.01M$-91.04M-
Surprise %----7.98%----

CAMP Forecast FAQ

Is CAMP4 Therapeutics stock a buy?

CAMP4 Therapeutics stock has a consensus rating of Buy, based on 22 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 6 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that CAMP4 Therapeutics is a favorable investment for most analysts.

What is CAMP4 Therapeutics's price target?

CAMP4 Therapeutics's price target, set by 22 Wall Street analysts, averages $17.5 over the next 12 months. The price target range spans from $17 at the low end to $18 at the high end, suggesting a potential 783.84% change from the previous closing price of $1.98.

How does CAMP4 Therapeutics stock forecast compare to its benchmarks?

CAMP4 Therapeutics's stock forecast shows a 783.84% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for CAMP4 Therapeutics over the past three months?

  • April 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is CAMP4 Therapeutics’s EPS forecast?

CAMP4 Therapeutics's average annual EPS forecast for its fiscal year ending in November 2024 is $-2.1, marking a -16.67% decrease from the reported $-2.52 in 2023. Estimates for the following years are $0.95 in 2025, $-2.42 in 2026, and $0 in 2027.

What is CAMP4 Therapeutics’s revenue forecast?

CAMP4 Therapeutics's average annual revenue forecast for its fiscal year ending in November 2024 is $229.1M, reflecting a 23.02% increase from the reported $186.23M in 2023. The forecast for 2025 is $252.01M, followed by $291.96M for 2026, and $152.47M for 2027.

What is CAMP4 Therapeutics’s net income forecast?

CAMP4 Therapeutics's net income forecast for the fiscal year ending in November 2024 stands at $-77.748M, representing a -16.63% decrease from the reported $-93.261M in 2023. Projections indicate $34.69M in 2025, $-89.576M in 2026, and $0 in 2027.